Samlyn Capital’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Samlyn Capital’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-319,432	Closed	-$36.4M	–	127
2022 Q4	$36.4M	Sell	319,432 -1,242,001	-80%	-$103M	0.71%	49
2022 Q3	$96.6M	Sell	1,561,433 -1,158,049	-43%	-$80.9M	1.8%	19
2022 Q2	$217M	Buy	2,719,482 +265,447	+11%	+$25.1M	4.33%	5
2022 Q1	$258M	Buy	2,454,035 +789,021	+47%	+$76.9M	3.71%	4
2021 Q4	$179M	Buy	1,665,014 +521,934	+46%	+$56.9M	2.48%	9
2021 Q3	$125M	Sell	1,143,080 -77,042	-6%	-$8M	1.68%	19
2021 Q2	$114M	Buy	1,220,122 +191,922	+19%	+$17.7M	1.68%	19
2021 Q1	$94.6M	Sell	1,028,200 -216,112	-17%	-$18.2M	1.31%	30
2020 Q4	$91M	Buy	1,244,312 +525,296	+73%	+$39M	1.3%	23
2020 Q3	$55.9M	Sell	719,016 -836,600	-54%	-$57.6M	1.01%	30
2020 Q2	$86.5M	Sell	1,555,616 -108,688	-7%	-$4.65M	1.6%	19
2020 Q1	$49.3M	Buy	1,664,304 +486,771	+41%	+$16.5M	1.24%	32
2019 Q4	$42.6M	Buy	1,177,533 +142,700	+14%	+$4.38M	0.89%	40
2019 Q3	$28.2M	Buy	1,034,833 +271,383	+36%	+$7.02M	0.68%	55
2019 Q2	$18.4M	Buy	763,450 +475,457	+165%	+$12.1M	0.39%	74
2019 Q1	$7.61M	Buy	+287,993	New	+$6.82M	0.18%	86
2016 Q4	–	Sell	-728,700	Closed	-$13.2M	–	161
2016 Q3	$13.2M	Buy	+728,700	New	+$14.2M	0.31%	91

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Samlyn Capital's HZNP Position: Q1 2023 in Review

Samlyn Capital sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 319,432 shares — an estimated $36.4M sold.

Samlyn Capital first reported a position in HZNP in Q3 2016 and held it in 17 quarters. The position peaked at $258M in Q1 2022. 552 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Samlyn Capital reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Samlyn Capital sold 319,432 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $36.4M.
Samlyn Capital first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016 and held it in 17 quarters.
Samlyn Capital's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $258M in Q1 2022.
552 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Samlyn Capital's 13F filing for Q1 2023, filed 15 May 2023.